Acanthamoeba Keratitis
Acanthamoeba Keratitis
This patient-education article is written by the cornea service at Suraj Eye Institute, Nagpur.
What is Acanthamoeba Keratitis?
Acanthamoeba is a free-living amoeba found in soil, freshwater, tap water and biofilms. It is an uncommon but very serious cause of corneal infection in contact lens wearers, particularly those who use tap water for lens cleaning, rinse cases under the tap, swim in lenses or sleep in them. The infection is notoriously difficult to diagnose early and to treat — both delays in diagnosis and resistance of the cyst form to most disinfectants make it a feared complication of lens wear.
Risk Factors
- Contact lens wear — the dominant risk factor
- Tap water — rinsing lens cases under the tap, topping up solution with water, showering or swimming in lenses
- Overnight lens wear
- Use of homemade or non-sterile cleaning solutions
- Outdoor exposure to soil and stagnant water
Symptoms
The classical story is a contact-lens wearer with several weeks of progressively worsening pain, redness and blurred vision. The pain is characteristically severe and out of proportion to the clinical signs — an important diagnostic clue. The eye often has been treated for several weeks with topical antibiotics and / or antivirals without improvement before the correct diagnosis is reached.
How Acanthamoeba Keratitis is Diagnosed
Diagnosis is often delayed. The key investigations are:
- In vivo confocal microscopy visualises Acanthamoeba cysts in the corneal stroma without scraping — the most useful single bedside test where available
- Corneal scraping for microscopy (calcofluor white stain), and culture on a non-nutrient agar plate seeded with E. coli (Acanthamoeba feeds on the bacteria)
- PCR on the corneal scraping
Treatment
Treatment is prolonged — usually several months — and combines drugs targeting the trophozoite and the cyst form:
- Topical biguanide — polyhexamethylene biguanide (PHMB) 0.02 % or chlorhexidine 0.02 %, hourly initially
- Topical diamidine — propamidine isethionate 0.1 % or hexamidine
- Cycloplegic drops and oral analgesia for pain control
- Topical steroids are usually avoided early; they may be carefully introduced later under specialist supervision to reduce immune-mediated stromal damage
- Therapeutic corneal transplantation for severe disease unresponsive to medical therapy — with the knowledge that recurrence in the graft is possible
We offer high-resolution confocal microscopy when available, prompt microbiological work-up on corneal scrapings, and intensive long-duration topical biguanide therapy (PHMB or chlorhexidine) combined with propamidine isethionate. For severe disease unresponsive to medical treatment we offer therapeutic corneal transplantation, with the understanding that recurrence in the graft is possible.
Frequently Asked Questions
